Developer docs
API playgroundTry for free, no card

Search company profiles

Think Biosolution

Full company profile

uuid0004atq

Namestring
Think Biosolution
Legal namestring
Think Biosolution Limited
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Think Biosolution Limited is a privately held, Ireland-incorporated health-technology company (founded circa 2015-2016) that builds an AI-driven chronic disease prevention platform for the long-term care and assisted living market. The company's core product, branded as the Chronic Disease Prevention Platform with the Hyperdetect AI Predictive Engine, combines Remote Patient Monitoring (RPM), wearable biosensors (PulseR launched 2016 and the QuasaR concept), and the Alexa-based NurseAnn voice-activated nursing assistant to detect co-morbid chronic conditions (cardiac, hypertension, diabetes, stroke) at mild stages in older residents. The CareManage™ module allows nurse managers to define a care pathway strategy and automatically translates it into a personalized care-pathway recommendation for each resident, and the platform integrates with multiple existing EHRs in the long-term care marketplace.

The company reports outcome claims of reducing cost of care by $8,868.23 per resident per year and saving nurse managers up to two hours per patient per month, while also shortening hospital length of stay. Think Biosolution operates from Dublin (NDRC, Digital Exchange) and Rochester, NY (Suite 6385, 260 East Main St), with leadership including CEO Dr. Shourjya Sanyal, CTO Koushik Kumar Nundy, and Product Engineering & Regulatory Affairs Manager Ash Watson.

The business model combines a recurring subscription/enterprise SaaS sale to long-term care operators (quote-based, with no public pricing) with channel partner and OEM/embedded licensing of Hyperdetect to Home Health Care providers and Medical Device manufacturers, supported by dedicated sell-sheet PDFs. Additional revenue is generated from hardware sales of branded wearables. Marketing is dominated by earned media across Irish, US, and European outlets, supplemented by accelerator visibility (Luminate NY, NDRC, InNEVator, Google Adopt a Startup, SPIE), YouTube video, and partner referrals. Capital to date has come primarily from accelerator grants and competition prizes totaling roughly $1.05M (NDRC, Luminate NY, InNEVator, and several smaller post-2018 rounds), with no disclosed venture funding.

Short descriptiontext

Think Biosolution builds an AI-driven chronic disease prevention platform — combining the Hyperdetect predictive engine, Alexa-based NurseAnn voice assistant, and CareManage™ pathway tool — for assisted living, long-term care, and home health care operators serving older residents with cardiac, hypertension, diabetes, or stroke conditions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDublin, Ireland
HQ citystring
Dublin
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
chronic disease prevention, remote patient monitoring, long-term care software, wearable health sensors, AI predictive healthcare
Industry1 code
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code2 codes
  • Nursing and Residential Care Facilities623
  • Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly6233
SIC code1 code
  • Services-Home Health Care Services8082
Product category
Remote Patient Monitoring Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Long-Term Care Platform Subscription
TypeSubscription Recurring
Description

Recurring SaaS-style revenue from long-term care and assisted living facilities using the Hyperdetect chronic disease prevention platform. Sells via direct enterprise sales and through channel partners with co-branded sell sheets.

thinkbiosolution.com
2Channel/OEM Partnerships (Home Health Care & Medical Device)
TypeLicensing Royalties
Description

Revenue from Home Health Care partners and Medical Device partners reselling or embedding Hyperdetect technology. Enablement materials and partnership PDFs published for these channels.

thinkbiosolution.com
3Hardware (Wearable Devices) Sales
TypeHardware Sales
Description

One-time sales of branded wearable biosensors (PulseR, QuasaR) that feed data into the chronic disease prevention platform.

thinkbiosolution.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Quote-based enterprise pricing for long-term care facilities
ModelOther
Notes

Pricing is not publicly disclosed on the website. Customers are directed to "Schedule a meeting" with the company, indicating custom/quote-based enterprise pricing. No tiers, list prices, or free trial information are published.

thinkbiosolution.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1PulseR
Description

Wearable device launched by Think Biosolution in 2016.

thinkbiosolution.com
+3 more records
Core offering1 text field

Think Biosolution provides an AI-driven Chronic Disease Prevention Platform (Hyperdetect) for long-term care and assisted living facilities, combining remote patient monitoring, the CareManage™ care-pathway management tool, the voice-activated NurseAnn (Alexa-based) nursing assistant, and wearable biosensors (PulseR, QuasaR) to detect co-morbid chronic conditions (cardiac, hypertension, diabetes, stroke) at mild stages and translate nurse-defined strategies into personalized resident care pathways.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduces cost of care by $8,868.23 per resident per year by detecting multiple chronic conditions at mild stages
+3 more records
Product overview1 text field

Think Biosolution offers a single unified Chronic Disease Prevention Platform for the long-term care market, delivered as a core AI- and Remote Patient Monitoring-based product with named add-on modules and devices. The core platform delivers end-to-end patient monitoring for older people and residents with cardiac, hypertension, stroke, or diabetic conditions, and incorporates the CareManage™ care pathway management module to translate nurse-defined strategies into personalized care-pathway recommendations. NurseAnn is a voice-activated nursing assistant (built on Alexa) layered onto the platform to collect patient information, assist with vitals collection, and deliver medication reminders. Earlier hardware offerings such as PulseR (launched 2016) and the QuasaR wearable concept extend the platform's remote-monitoring reach.

Product and service5 records
1Hyperdetect Chronic Disease Prevention Platform
CategoryAI-driven chronic disease prevention platform
Description

End-to-end AI- and Remote Patient Monitoring-based platform for long-term care facilities, focused on early detection and management of chronic conditions such as cardiac disease, hypertension, and diabetes in older residents and people with cardiac conditions, stroke, or hypertension.

2CareManage
3NurseAnn
4PulseR
CategoryWearable health-monitoring device
Description

Wearable health-monitoring product launched in September 2016 for accurate on-the-go health monitoring, referenced in the company's 2016 press release.

5QuasaR
CategoryWearable health-monitoring device
Description

Wearable device referenced in 2018 press coverage as a next-generation wearable for continuous health monitoring, positioned as 'the future of wearable devices.'

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2017-09-30
Description

Selected as one of three IoT companies for the InNEVator 2017 six-week accelerator in Reno, Nevada (launched October 2, 2017). Builds US credibility and connections to Northern Nevada IoT ecosystem.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2017-01-01
Description

Selected as one of 31 start-ups in Google's "Adopt a Startup 2017" mentorship program. Provides GTM mentorship and exposure rather than capital.

3SPIE Startup Challenge 2017
Strategic tierMinorTypeOthersAnnounced on2017-01-01
Description

Semi-finalist in the SPIE Startup Challenge 2017 at Photonics West (covered by BioOptics World and SPIE). Industry competition relevant to optics/photonics positioning of the wearable biosensor products.

thinkbiosolution.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Channel partner program targeting Home Health Care resellers/distributors, supported by a dedicated Sell_Sheet_Hyperdetect_HHC.pdf sales sheet and listed as a "Digital Sales Support Material" on the Long Term Care page. Partners resell or co-deliver Hyperdetect-enabled home monitoring.

5Medical Device OEM Partners (unnamed)
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

OEM/embedded channel for medical device manufacturers to integrate or white-label Hyperdetect into their devices. Supported by a dedicated Partnership_Hyperdetect_MedDevice.pdf and listed under "Digital Sales Support Material" alongside the Home Health Care sell sheet.

thinkbiosolution.com
Strategic tierMinorTypeOthers
Description

Seven partner logos are displayed under the "PARTNERS" banner on the homepage (thinkbiosolution.com) but the underlying partner names are not captioned in the source. Likely a mix of channel, technology, and pilot partners within the long-term care ecosystem.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Biofourmis
TypeDirect peer
Description

AI-based predictive analytics platform layered on continuous biosensor data for chronic and post-acute care. Comparable in combining AI predictive engine + wearable biosensors for chronic-disease management.

TypeEmerging player
Description

Voice-first care assistant for senior living and home health using smart speakers. Directly comparable to Think Biosolution's NurseAnn Alexa-based nursing assistant for medication reminders and resident interaction.

TypeBroad incumbent
Description

Established RPM platform from Optum/UHG offering chronic-care remote monitoring to health systems and payers. Competes broadly with Think Biosolution's chronic-disease platform via scale and payer relationships.

TypeDirect peer
Description

AI-driven wearable and analytics platform for senior living and assisted living populations, predicting health declines and ADL changes. Closely comparable to Think Biosolution's Hyperdetect approach of combining wearables + AI for early chronic-condition detection in older residents.

TypeBroad incumbent
Description

European-headquartered telecare and RPM provider with deep penetration in assisted living and home health. Comparable vertically focused on senior populations; Think Biosolution's Irish HQ and long-term care focus put it in overlapping European and US geographies.

TypeDirect peer
Description

AI-enabled RPM platform combining a wearable and predictive analytics for chronic and post-acute care; acquired by Best Buy to scale hospital-at-home. Comparable AI + wearable stack for chronic-disease patients.

7Health Recovery Solutions (HRS)
TypeDirect peer
Description

RPM platform focused on chronic disease management (cardiac, COPD, diabetes) for home health and post-acute care. Overlaps with Think Biosolution's HHC channel and chronic-condition use cases.

8VitalConnect
TypeDirect peer
Description

Wearable biosensor patch (VitalPatch) plus remote cardiac and vital-sign monitoring platform sold to hospitals and home health. Comparable to Think Biosolution's PulseR/QuasaR wearables feeding a chronic-disease platform.

TypeBroad incumbent
Description

Broad RPM portfolio from Philips covering hospital, home, and chronic-disease monitoring. Represents the incumbent scale competitor that Think Biosolution must displace in long-term care procurement.

TypeDirect peer
Description

Contact-free continuous monitoring sensors and analytics for skilled nursing, assisted living, and hospitals. Direct competitor in the long-term care RPM and early-detection niche that Think Biosolution targets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Think Biosolution

Remote Patient Monitoring Softwarethinkbiosolution.com

Think Biosolution builds an AI-driven chronic disease prevention platform — combining the Hyperdetect predictive engine, Alexa-based NurseAnn voice assistant, and CareManage™ pathway tool — for assisted living, long-term care, and home health care operators serving older residents with cardiac, hypertension, diabetes, or stroke conditions.

What Think Biosolution does

Think Biosolution Limited is a privately held, Ireland-incorporated health-technology company (founded circa 2015-2016) that builds an AI-driven chronic disease prevention platform for the long-term care and assisted living market. The company's core product, branded as the Chronic Disease Prevention Platform with the Hyperdetect AI Predictive Engine, combines Remote Patient Monitoring (RPM), wearable biosensors (PulseR launched 2016 and the QuasaR concept), and the Alexa-based NurseAnn voice-activated nursing assistant to detect co-morbid chronic conditions (cardiac, hypertension, diabetes, stroke) at mild stages in older residents. The CareManage™ module allows nurse managers to define a care pathway strategy and automatically translates it into a personalized care-pathway recommendation for each resident, and the platform integrates with multiple existing EHRs in the long-term care marketplace.

The company reports outcome claims of reducing cost of care by $8,868.23 per resident per year and saving nurse managers up to two hours per patient per month, while also shortening hospital length of stay. Think Biosolution operates from Dublin (NDRC, Digital Exchange) and Rochester, NY (Suite 6385, 260 East Main St), with leadership including CEO Dr. Shourjya Sanyal, CTO Koushik Kumar Nundy, and Product Engineering & Regulatory Affairs Manager Ash Watson.

The business model combines a recurring subscription/enterprise SaaS sale to long-term care operators (quote-based, with no public pricing) with channel partner and OEM/embedded licensing of Hyperdetect to Home Health Care providers and Medical Device manufacturers, supported by dedicated sell-sheet PDFs. Additional revenue is generated from hardware sales of branded wearables. Marketing is dominated by earned media across Irish, US, and European outlets, supplemented by accelerator visibility (Luminate NY, NDRC, InNEVator, Google Adopt a Startup, SPIE), YouTube video, and partner referrals. Capital to date has come primarily from accelerator grants and competition prizes totaling roughly $1.05M (NDRC, Luminate NY, InNEVator, and several smaller post-2018 rounds), with no disclosed venture funding.

Think Biosolution firmographics

Firmographics
Name
Think Biosolution
Legal name
Think Biosolution Limited
Website
https://thinkbiosolution.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Think Biosolution builds an AI-driven chronic disease prevention platform — combining the Hyperdetect predictive engine, Alexa-based NurseAnn voice assistant, and CareManage™ pathway tool — for assisted living, long-term care, and home health care operators serving older residents with cardiac, hypertension, diabetes, or stroke conditions.
Ownership category
akta.pro rank

Think Biosolution industry classification

Industry
Product category
Remote Patient Monitoring Software
NAICS
Nursing and Residential Care Facilities (623), Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly (6233)
SIC
Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Chronic disease prevention
  • Remote patient monitoring
  • Long-term care software
  • Wearable health sensors
  • AI predictive healthcare

Where Think Biosolution is headquartered

Location

Headquarters

HQ city
Dublin
HQ country
Ireland
HQ region
Europe

Offices2 records

Markets served

Think Biosolution business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Long-Term Care Platform Subscription: Recurring SaaS-style revenue from long-term care and assisted living facilities using the Hyperdetect chronic disease prevention platform. Sells via direct enterprise sales and through channel partners with co-branded sell sheets.
  2. Channel/OEM Partnerships (Home Health Care & Medical Device): Revenue from Home Health Care partners and Medical Device partners reselling or embedding Hyperdetect technology. Enablement materials and partnership PDFs published for these channels.
  3. Hardware (Wearable Devices) Sales: One-time sales of branded wearable biosensors (PulseR, QuasaR) that feed data into the chronic disease prevention platform.

Pricing tiers

ModelBillingPrice
Other—Quote-based enterprise pricing for long-term care facilities

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Think Biosolution product offering

Product offering

Core offering

Think Biosolution provides an AI-driven Chronic Disease Prevention Platform (Hyperdetect) for long-term care and assisted living facilities, combining remote patient monitoring, the CareManage™ care-pathway management tool, the voice-activated NurseAnn (Alexa-based) nursing assistant, and wearable biosensors (PulseR, QuasaR) to detect co-morbid chronic conditions (cardiac, hypertension, diabetes, stroke) at mild stages and translate nurse-defined strategies into personalized resident care pathways.

Product overview

Think Biosolution offers a single unified Chronic Disease Prevention Platform for the long-term care market, delivered as a core AI- and Remote Patient Monitoring-based product with named add-on modules and devices. The core platform delivers end-to-end patient monitoring for older people and residents with cardiac, hypertension, stroke, or diabetic conditions, and incorporates the CareManage™ care pathway management module to translate nurse-defined strategies into personalized care-pathway recommendations. NurseAnn is a voice-activated nursing assistant (built on Alexa) layered onto the platform to collect patient information, assist with vitals collection, and deliver medication reminders. Earlier hardware offerings such as PulseR (launched 2016) and the QuasaR wearable concept extend the platform's remote-monitoring reach.

Differentiator

Problem solved

Functional benefit

Brands

  • PulseR: Wearable device launched by Think Biosolution in 2016.
  • QuasaR
  • NurseAnn
  • CareManage

Products and services

  • Hyperdetect Chronic Disease Prevention Platform End-to-end AI- and Remote Patient Monitoring-based platform for long-term care facilities, focused on early detection and management of chronic conditions such as cardiac disease, hypertension, and diabetes in older residents and people with cardiac conditions, stroke, or hypertension.
  • CareManage
  • NurseAnn
  • PulseR Wearable health-monitoring product launched in September 2016 for accurate on-the-go health monitoring, referenced in the company's 2016 press release.
  • QuasaR Wearable device referenced in 2018 press coverage as a next-generation wearable for continuous health monitoring, positioned as 'the future of wearable devices.'

Quantifiable outcome

  • Reduces cost of care by $8,868.23 per resident per year by detecting multiple chronic conditions at mild stages
  • +3 more outcomes

Companies that use Think Biosolution

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Think Biosolution technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Think Biosolution partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • InNEVator (University of Nevada, Reno)minorStrategic or Co-development Partner · 30 September 2017Selected as one of three IoT companies for the InNEVator 2017 six-week accelerator in Reno, Nevada (launched October 2, 2017). Builds US credibility and connections to Northern Nevada IoT ecosystem.
  • Google (Adopt a Startup 2017)minorGTM or Marketing Partner · 1 January 2017Selected as one of 31 start-ups in Google's "Adopt a Startup 2017" mentorship program. Provides GTM mentorship and exposure rather than capital.
  • SPIE Startup Challenge 2017minorOthers · 1 January 2017Semi-finalist in the SPIE Startup Challenge 2017 at Photonics West (covered by BioOptics World and SPIE). Industry competition relevant to optics/photonics positioning of the wearable biosensor products.
  • Home Health Care Channel Partners (unnamed)coreChannel Partner/ Reseller/ DistributorChannel partner program targeting Home Health Care resellers/distributors, supported by a dedicated Sell_Sheet_Hyperdetect_HHC.pdf sales sheet and listed as a "Digital Sales Support Material" on the Long Term Care page. Partners resell or co-deliver Hyperdetect-enabled home monitoring.
  • Medical Device OEM Partners (unnamed)coreOEM/ Whitelabel/ Licensing PartnerOEM/embedded channel for medical device manufacturers to integrate or white-label Hyperdetect into their devices. Supported by a dedicated Partnership_Hyperdetect_MedDevice.pdf and listed under "Digital Sales Support Material" alongside the Home Health Care sell sheet.
  • Long-Term Care Partner Logos (7 unnamed organizations)minorOthersSeven partner logos are displayed under the "PARTNERS" banner on the homepage (thinkbiosolution.com) but the underlying partner names are not captioned in the source. Likely a mix of channel, technology, and pilot partners within the long-term care ecosystem.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Think Biosolution competitors and assessment

Company assessment

Direct peers

  • Biofourmis: AI-based predictive analytics platform layered on continuous biosensor data for chronic and post-acute care. Comparable in combining AI predictive engine + wearable biosensors for chronic-disease management.
  • CarePredict: AI-driven wearable and analytics platform for senior living and assisted living populations, predicting health declines and ADL changes. Closely comparable to Think Biosolution's Hyperdetect approach of combining wearables + AI for early chronic-condition detection in older residents.
  • Current Health (Best Buy Health): AI-enabled RPM platform combining a wearable and predictive analytics for chronic and post-acute care; acquired by Best Buy to scale hospital-at-home. Comparable AI + wearable stack for chronic-disease patients.
  • Health Recovery Solutions (HRS): RPM platform focused on chronic disease management (cardiac, COPD, diabetes) for home health and post-acute care. Overlaps with Think Biosolution's HHC channel and chronic-condition use cases.
  • VitalConnect: Wearable biosensor patch (VitalPatch) plus remote cardiac and vital-sign monitoring platform sold to hospitals and home health. Comparable to Think Biosolution's PulseR/QuasaR wearables feeding a chronic-disease platform.
  • EarlySense: Contact-free continuous monitoring sensors and analytics for skilled nursing, assisted living, and hospitals. Direct competitor in the long-term care RPM and early-detection niche that Think Biosolution targets.

Emerging players

  • Aiva Health: Voice-first care assistant for senior living and home health using smart speakers. Directly comparable to Think Biosolution's NurseAnn Alexa-based nursing assistant for medication reminders and resident interaction.

Broad incumbents

  • Vivify Health (Optum): Established RPM platform from Optum/UHG offering chronic-care remote monitoring to health systems and payers. Competes broadly with Think Biosolution's chronic-disease platform via scale and payer relationships.
  • Tunstall Healthcare: European-headquartered telecare and RPM provider with deep penetration in assisted living and home health. Comparable vertically focused on senior populations; Think Biosolution's Irish HQ and long-term care focus put it in overlapping European and US geographies.
  • Philips Remote Patient Monitoring: Broad RPM portfolio from Philips covering hospital, home, and chronic-disease monitoring. Represents the incumbent scale competitor that Think Biosolution must displace in long-term care procurement.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights5 records

Customer concentration

Think Biosolution social profiles

Digital presence

Think Biosolution financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Think Biosolution leadership team

Management profile

Number of profiles

Profiles3 records

Think Biosolution funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Think Biosolution M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Think Biosolution

What does Think Biosolution do?

Think Biosolution provides an AI-driven Chronic Disease Prevention Platform (Hyperdetect) for long-term care and assisted living facilities, combining remote patient monitoring, the CareManage™ care-pathway management tool, the voice-activated NurseAnn (Alexa-based) nursing assistant, and wearable biosensors (PulseR, QuasaR) to detect co-morbid chronic conditions (cardiac, hypertension, diabetes, stroke) at mild stages and translate nurse-defined strategies into personalized resident care pathways.

Is Think Biosolution a public or private company?

Think Biosolution is a private company. It is classified as venture growth investor backed and is currently operating.

When was Think Biosolution founded?

Think Biosolution was founded in 2015. It employs 1 to 10 people.

Where is Think Biosolution based?

Think Biosolution is headquartered in Dublin, Ireland, in the Europe region.

How does Think Biosolution make money?

Three revenue lines are on record. Long-Term Care Platform Subscription is the primary driver. The others are channel/OEM Partnerships (Home Health Care & Medical Device) and hardware (Wearable Devices) Sales.

Who are Think Biosolution's main competitors?

Direct peers on record are Biofourmis, CarePredict, Current Health (Best Buy Health), Health Recovery Solutions (HRS), VitalConnect and EarlySense. Aiva Health is listed as an emerging player. Broad incumbents are Vivify Health (Optum), Tunstall Healthcare and Philips Remote Patient Monitoring.

Does Think Biosolution have an API?

No public API is recorded for Think Biosolution.

What industry is Think Biosolution in?

Think Biosolution's product category is Remote Patient Monitoring Software. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 623 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Ceiba-Health5 Top Telemedicine Startups Impacting The Healthcare IndustryAn analysis of emerging healthcare technologies highlights five telemedicine startups—Ceiba Healthcare, Think Biosolution, Synapse Healthcare Solutions, Lumed, and AssayMe—that are addressing critical care needs during the pandemic. These companies provide diverse remote healthcare solutions, including AI-based ICU monitoring, wearable vital sign tracking, asynchronous medical data sharing, synchronous video consultations, and at-home diagnostic testing.NextCorpsSpotlight on Think Biosolution: Enabling Customized Remote Patient MonitoringThink Biosolution's QuasaR is a remote patient monitoring device that pairs with a HIPAA-compliant cloud and EHR-integrated clinical dashboards. The device aims to give providers more information about patients over time, addressing the lack of complete patient pictures in hospital or clinical settings.Silicon Republic17 health sciences start-ups from Ireland to watchSeventeen Irish health sciences start-ups are profiled, covering biotech, medtech, and diagnostics. APC, Diaceutics, and Genomics Medicine Ireland are among them, with funding rounds and job expansions noted. The list highlights innovation in areas like synthetic biology and regenerative medicine.Silicon RepublicDublin’s Think Biosolution wins $250,000 investment at Luminate NYDublin-based Think Biosolution won $250,000 at Luminate NY, one of four companies in the first round. The award is part of a $1.5m Series A round, with manufacturing and go-to-market planned by Q1 2019.Osa-opnN.Y. Startup Accelerator Names First WinnersLuminate NY announced its first Demo Day winners, with Double Helix Optics winning US$1 million in follow-on funding. Intelon Optics, Positive Science, and Think Biosolution received cash grants, and applications for round 2 are open through September 24, 2018.RbjLuminate startup makes ‘Fitbit on steroids’Think Biosolution, a Luminate NY accelerator startup, is developing the QuasaR device, an egg-shaped biometric tracker using camera sensors for medical-grade accuracy. The company plans to produce 12,000 units in Rochester by Q3 2019 and target sports teams and health marketplaces.Irish ExaminerThe technology of fighting the flabThink Biosolution's QuasaR is a chest-strap device using a camera sensor to measure heart rate, respiratory rate, and blood oxygen, with AI voice feedback for running intensity. The company has raised $200,000 and seeks $300,000 more, targeting 20,000 units and $3m in sales by 2018.Silicon RepublicIrish health sensor start-up secures $100,000 to join US acceleratorDublin-based Think Biosolution received $100,000 after being named one of 10 finalists in the Luminate NY accelerator. The wearable device QuasaR targets obesity, stress, and heart conditions. The company will join the program in January and compete for over $2m in follow-on funding.Silicon RepublicStart-up of the week: Think BiosolutionDublin-based Think Biosolution developed QuasaR, a wearable wellness trainer that suggests exercise routines based on health parameters. The company targets a €175bn market and plans to license the product to apparel brands, with a pre-trial by Q2 2017 and soft launch in Q3 2017.Silicon RepublicESGI event gets academics to solve real-world industry issuesThe European Study Group with Industry (ESGI) event, organized by UCD, brings researchers and seven companies together to solve real-world engineering and software problems. The week-long workshop, first held in 1968, includes challenges like steel defects and an artificial pancreas algorithm, with over 70 researchers from multiple countries.